Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q2

6523.TEDINET S100PICM
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥170.6bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥89.1bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥340.5bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥166.1bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥85.1bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥10.5bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥8.5bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥13.5bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥7.9bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥3.4bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥9.7bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥3.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥20.1bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥6.0bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥1.2bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥8.3bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥15.0bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.6bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥8.5bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥15.1bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥4.6bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥596.3bnat 2022-09-30Cons.Assets IFRS
Total assets¥591.3bnat 2022-03-31Cons.Assets IFRS
Total assets¥569.2bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥446.9bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥455.3bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥149.3bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥124.1bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥107.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥148.3bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥135.4bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥123.5bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥73.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥59.6bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.8bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥5.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥51.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥20.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥8.4bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥12.5bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥6.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥20.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥7.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥14.8bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥9.612022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥66.62022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-70.782021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥129.062021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥39.672021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥9.522022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥65.982022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-70.782021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥125.012021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥38.422021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio24.9%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio22.9%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio21.7%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30¥1.1bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-09-30¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥9.4bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-09-30¥55.4bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-09-30¥55.4bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-09-30¥12.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-09-30¥49.3bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-09-30¥49.3bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.7bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-09-30¥64.8bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-09-30¥64.8bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-09-30¥5.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥169.5bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥169.5bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥20.0bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30¥1.4bn
Reconciling Itemsreconcilingrevenue external2021-04-01 → 2021-09-30¥1.4bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥8.8bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue2021-04-01 → 2021-09-30¥53.7bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue external2021-04-01 → 2021-09-30¥53.7bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentsegment profit2021-04-01 → 2021-09-30¥10.5bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2021-04-01 → 2021-09-30¥44.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2021-04-01 → 2021-09-30¥44.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2021-04-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue2021-04-01 → 2021-09-30¥66.9bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue external2021-04-01 → 2021-09-30¥66.9bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentsegment profit2021-04-01 → 2021-09-30¥8.8bn
—segment totalrevenue2021-04-01 → 2021-09-30¥164.6bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥164.6bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥22.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 976
ItemContextValueUnit
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant95232000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember124984532
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember125005474
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant124984532
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant125005474
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember47994000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.3847
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember21870000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1753
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember12297000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0986
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember11266000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0903
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember5714000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0458
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember4636000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0372
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember1522000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0122
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember674000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0054
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember549000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0044
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember440000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0035
Number of shares heldCurrentQuarterInstant106965000
Shareholding ratioCurrentQuarterInstant0.8573
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember211900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember124761600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1247616
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember11032
Number of shares issued shares voting rightsCurrentQuarterInstant124984532
Number of voting rights issued shares voting rightsCurrentQuarterInstant1247616
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member211900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member211900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0017
Number of shares held in own name treasury shares etcCurrentQuarterInstant211900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant211900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0017
Cash and cash equivalents IFRSPrior1YearInstant95232000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant73713000000JPY
Trade receivables ca IFRSPrior1YearInstant63727000000JPY
Trade receivables ca IFRSCurrentQuarterInstant62592000000JPY
Inventories ca IFRSPrior1YearInstant44509000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass